Sheldon J. Segal, Ph.D. is a distinguished scientist at the Population Council and recipient of the 2008 Prix Galien USA Pro Bono Humanum Award. He lives in New York City.
There is little incentive for drug companies to research treatments for rare diseases. But collaboration with nonprofits could make it happen. Posted on Sep 22, 2008, Source: AlterNet
